박병우 / PARK, Byeong-Woo
교수

Department / Institute / Center :
Department of Surgery
Yonsei University College of Medicine
Breast Cancer Clinic

Contact Information

Phone 82-2-2228-2121 +82-2-2228-2100 Email bwpark@yuhs.ac Website

Educational Background

Undergraduate Education Yonsei University College of Medicine
Final Degree (University, Major) Ph.D.Yonsei University, Medicine (oncogene)
Overseas Training (Institute, Supervisor) Department of Pathology & Lab Medicine,
Univ, of Penn, Dr. Mark I. Greene

Professional Societies and current positions

Korean Breast Cancer Society: Director of General Affair
Korea Society of Clinical Oncology: member
The Korean Surgical Society: member: member
Korean Cancer Association: member
European Association of Cancer Research: member

Research Area(s)

Translational research, Clinical research
Research Field The roles of Hormonal receptors (ER, PR, AR) and growth factor receptors in breast cancer development & progression
Crosstalks between Hormonal receptors (ER, PR, AR) and growth factor receptors
Biomarkers specific to molecular subtypes of breast cancers
Diseases Breast cancer:
Breast cancer carcinogenesis & mechanism of progression
The roles of Hormonal receptors, growth factor receptors in breast cancer
Biomarkers and their application in practice
Possible Collaboration Breast Cancer related translational researches:
Research regarding quality of life for breast cancer survivors

Research Methods

Tissue microarray blocks for breast cancer patients (over 1200 samples)
Immunohistochemical staining for various markers
Western/Northern/Southern blotting
Cell proliferation assay
Gene transfection and functional assay etc

Lab.

연구실사이트 바로가기
Location of Office 서대문구 성산로 250 임상연구동
Location of Lab. 임상연구동
Contact person Name: 이미정 / Tel: 82812 / E-mail: MJLee0216@yuhs.ac

Major Published Articles and Books

1.Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011 Feb 10. [Epub ahead of print]
2. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21:488-92

3. Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes. Ann Oncol. 2008;19:675-681.

4. The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development. J Surg Oncol 2006;93:504-510

5. Rationally designed anti-HER2/neu peptide mimetic disables p185HER2/neu tyrosine kinases in vitro and in vivo similar to monoclonal antibody. Nature Biotechnol 18: 194-198, 2000

6. Induction of Modulators of the 26S Proteasome Accompanies the Disabling of Oncogenic erbB Receptor Tyrosine Kinases. Proc Natl Acad Sci USA 96: 6434-6438, 1999